Procter & Gamble Company (0NOF)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 158.19 |
|---|---|
| 52-week range | 136.64 – 167.96 |
| Return, 1 month / 3 months | +7.2% / +5.8% |
| Return, 1 year / 3 years | +6.0% / +17.7% |
| Trend | Uptrend |
| RSI (14) | 75 |
| Volatility (1 year) | 27.0% |
| Worst drawdown (1 year) | -16.7% |
| Average daily value traded | 5.79M USD |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Procter & Gamble Company makes and sells everyday consumer goods in categories spanning beauty, grooming, health care, fabric and home care, and baby, feminine and family care. Its brands include laundry detergents, disposable diapers, razors, shampoos, toothpaste and paper products. Customers are households worldwide, and the products reach them through supermarkets, mass merchants, pharmacies and other retailers. The company is based in Cincinnati, Ohio, in the United States.
Procter & Gamble Company trades under the code 0NOF on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Procter & Gamble Company (0NOF) trades on the London Exchange in UK. It last closed at USD 158.19 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 754 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.0% and over the last three months it rose 5.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.9% | ||
| From 52-week high | -5.0% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.8% | ||
| 6-month return | 9.5% | ||
| 12-month return, skipping the last month | -1.1% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.7% | ||
| Liquidity | 69 · Fair | Moderate trading activity. | |
| Average daily value traded | 5.79M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.6% |
|---|---|
| 1 month | +7.2% |
| 3 months | +5.8% |
| 6 months | +9.5% |
| 1 year | +6.0% |
| 3 years | +17.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 146.99 / 147.95 |
|---|---|
| Golden / death cross (60 days) | Death, 39 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jan 2026 | USD 1.0568 |
| 24 Oct 2025 | USD 1.0568 |
| 17 Jul 2025 | USD 1.0568 |
| 17 Apr 2025 | USD 1.0568 |
| 23 Jan 2025 | USD 1.0065 |
| 17 Oct 2024 | USD 1.0065 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.